Published in Gut on November 01, 2002
Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28
Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70
High-grade dysplasia in Barrett's oesophagus. The case against oesophageal resection. Ann R Coll Surg Engl (2007) 1.47
Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol (2010) 1.35
What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut (2004) 1.29
Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut (2005) 1.18
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Gastroenterology (2015) 1.10
Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc (2007) 1.03
Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch (2013) 0.96
Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol (2006) 0.93
Approach to early Barrett's cancer. World J Surg (2003) 0.93
Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol (2016) 0.88
Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol (2004) 0.87
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag (2011) 0.86
Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist. World J Surg Oncol (2006) 0.86
Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol (2010) 0.85
INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma. Virchows Arch (2004) 0.84
The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Am J Gastroenterol (2015) 0.83
Molecular markers and staging of early esophageal cancer. Langenbecks Arch Surg (2003) 0.82
Barrett's esophagus with high-grade dysplasia: focus on current treatment options. World J Gastroenterol (2011) 0.82
In vivo cancer biomarkers of esophageal neoplasia. Cancer Biomark (2008) 0.82
Endoscopic therapy for Barrett's oesophagus. Gut (2005) 0.82
Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus. J Gastrointest Surg (2010) 0.79
Diagnosis and management of Barrett's esophagus for the endoscopist. Therap Adv Gastroenterol (2010) 0.78
Endoscopic screening and surveillance for Barrett's esophagus--clinical implications. MedGenMed (2006) 0.78
Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol (2011) 0.77
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works? Gut (2002) 0.77
Endoscopic mucosal resection in the setting of Barrett's esophagus. Can J Gastroenterol (2007) 0.76
Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability. Endosc Int Open (2016) 0.75
Accuracy of identification of tissue types in endoscopic esophageal mucosal biopsies used for molecular biology studies. Clin Exp Gastroenterol (2009) 0.75
Barrett's Esophagus: Diagnosis and Management. Gastrointest Endosc (2017) 0.75
[Barrett's esophagus. An update]. Pathologe (2012) 0.75
Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol (2016) 0.75
New Consensus on the Management of Barrett's Dysplasia and Early Stage Esophageal Adenocarcinoma: Limited Evidence, but Best Available Guidance (Gastroenterology 2012;143:336-346). J Neurogastroenterol Motil (2012) 0.75
Separating bad from worse in Barrett's esophagus. Gastroenterology (2003) 0.75
The histological appearance of oesophageal adenocarcinoma--an analysis based on 215 resection specimens. Virchows Arch (2006) 0.75
[Barrett's esophagus and carcinoma : Recommendations of the S2k guideline 2014 and the S3 guideline 2015]. Pathologe (2016) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol (1988) 3.67
Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg (1983) 2.91
The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol (1987) 2.31
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology (1988) 2.06
Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol (1993) 1.95
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg (1992) 1.54
Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients. Am J Surg Pathol (1985) 1.46
Surgical therapy in Barrett's esophagus. Ann Surg (1990) 1.43
The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg (1996) 1.39
High-grade dysplasia in the columnar-lined esophagus. Am J Surg (1991) 1.29
Histopathologic characteristics of early stage esophageal carcinoma. A comparative study with gastric carcinoma. Cancer (1992) 1.18
In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer (1998) 1.15
Superficial squamous cell carcinoma of the esophagus. A report of 76 cases and review of the literature. Am J Surg Pathol (1989) 1.12
The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol (1995) 1.11
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut (1992) 1.08
Increased expression of the cyclin D1 gene in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (1996) 1.07
p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol (1996) 1.06
p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci (1997) 1.01
Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol (1995) 1.00
Long-term results of esophagectomy for early esophageal carcinoma. Hepatogastroenterology (1993) 0.92
Epithelial cell proliferative activity of Barrett's esophagus: methodology and correlation with traditional cancer risk markers. Dig Dis Sci (1998) 0.83
Diagnostic significance of nuclear p53 expression in the surveillance of Barrett's esophagus--a longitudinal study. Z Gastroenterol (1999) 0.82
Expression of cyclin D1, CDK4 and p27KIP1 is associated with the p16MTS1 gene status in human esophageal carcinoma cell lines. J Exp Ther Oncol (1996) 0.81
What is the ideal treatment for early esophageal cancer? Endoscopy (1993) 0.81
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69
Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol (1997) 4.18
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol (2001) 4.16
Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology (1994) 3.89
Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol (2000) 3.67
The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol (1988) 3.53
Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer (1999) 3.13
Esophageal manometry in 95 healthy adult volunteers. Variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci (1987) 3.07
The ringed esophagus: histological features of GERD. Am J Gastroenterol (2001) 3.06
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol (1995) 2.89
Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80
Dysphagia lusoria: a comprehensive review. Dis Esophagus (2007) 2.74
Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology (1998) 2.74
Gastrointestinal motility disorders during pregnancy. Ann Intern Med (1993) 2.70
Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med (1982) 2.63
A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol (1999) 2.57
Current therapies for achalasia: comparison and efficacy. J Clin Gastroenterol (1998) 2.45
Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut (1999) 2.44
Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A (1995) 2.44
Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc (1996) 2.44
Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology (1996) 2.44
Gastroesophageal reflux-induced bronchoconstriction. Is microaspiration a factor? Chest (1995) 2.40
Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut (2002) 2.39
Celiac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol (2001) 2.29
Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol (1993) 2.28
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26
The role of gastroesophageal reflux in chronic cough and asthma. Chest (1997) 2.25
Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg (1998) 2.25
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Esophageal injury during radiofrequency ablation for atrial fibrillation. J Thorac Cardiovasc Surg (2001) 2.11
Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology (1995) 2.02
Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients. Ann Intern Med (1987) 2.02
Using hub technology to facilitate information system integration in a health-care enterprise. Am J Clin Pathol (1996) 2.02
Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature. Am J Surg Pathol (1998) 1.99
Lobectomy--video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg (1995) 1.98
Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol (1993) 1.95
Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol (2001) 1.94
Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg (2001) 1.93
Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology. Gastroenterology (1997) 1.92
Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci (1988) 1.91
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc (1999) 1.90
24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest (1999) 1.90
Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology (1986) 1.87
The impact of thoracoscopy on the management of pleural disease. Chest (1995) 1.85
Leiomyosarcoma of the paratesticular region: a clinicopathologic study. Am J Surg Pathol (2001) 1.84
The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol (2000) 1.84
The gastric cardia: fact or fiction? Am J Gastroenterol (2000) 1.84
Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model. Am J Med (1994) 1.82
Treatment of achalasia: the best of both worlds. Am J Gastroenterol (1994) 1.82
Diffuse esophageal spasm. A rare motility disorder not characterized by high-amplitude contractions. Dig Dis Sci (1991) 1.81
Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest (1992) 1.80
Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology (1996) 1.79
The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci (1993) 1.75
The diagnostic and therapeutic utility of thoracoscopy. A review. Chest (1995) 1.75
Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol (2000) 1.75
Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol (1999) 1.74
Characteristics of distal partial gastrectomy patients with esophageal symptoms of duodenogastric reflux. Am J Gastroenterol (1995) 1.68
Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med (1995) 1.65
Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism. Eur Respir J (2009) 1.63
Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology (1994) 1.61
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol (2001) 1.61
Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. AJR Am J Roentgenol (1994) 1.58
Thoracoscopic lobectomy. Ann Thorac Surg (1993) 1.57
Gastroesophageal reflux and chronic cough. Am J Gastroenterol (2000) 1.57
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. Gastroenterology (1992) 1.57
Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Cancer (2001) 1.57
Diffuse esophageal spasm: a reappraisal. Ann Intern Med (1984) 1.57
Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery (1998) 1.56
Presentation and management of bronchogenic cysts in the adult. Chest (1994) 1.56
Myofibrosarcoma: a clinicopathologic study. Am J Surg Pathol (2001) 1.54
Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease. Gastroenterology (1994) 1.53
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis (1998) 1.53
CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol (2000) 1.53
Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest (1992) 1.49
Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases. Mod Pathol (1999) 1.44
Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators. J Am Coll Cardiol (1998) 1.42